Dr. Ayodele Ogunkeyede, a plastic, reconstructive and aesthetic surgeon with Hafar Al-batin Central Hospital, Hafar Albatin, Eastern Region, Saudi Arabia, has developed novel compression therapy for ...

First of Several Post-hoc Analyses Planned Using HOPE Study Clinical Data Findings Presented in Poster Session at 13 th Annual Academy for Sickle Cell and Thalassemia Conference SOUTH SAN FRANCISCO, ...

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...

Today, Kwincy Lassiter is a 25-year-old student enjoying a second chance at life. However, the first 16 years of his sickle cell journey looked much different.

RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...

Nikki Peterson, like approximately 100,000 other Americans, was born with sickle cell anemia. The 43-year-old lives in Upper Marlboro, Md., and ends up in the hospital about four times during what she ...

The MarketWatch News Department was not involved in the creation of this content. PRINCETON, NJ, Nov. 18, 2025 /CNW/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay ...

People with sickle cell anemia, especially children, are more likely to experience a stroke. Silent strokes, which don’t cause noticeable symptoms, are especially common. Sickle cell anemia (SCA) is a ...

Sickle cell disease is a hereditary condition, which means a person inherits it from their biological parents. The condition occurs when a person inherits two copies of the hemoglobin beta (HBB) gene ...